PTPRC and metabolic dysfunction-associated steatohepatitis: NASH mice treated with EV-HLSCs had a significant reduction of CD45 cell accumulation within the liver, indicating the anti-inflammatory and immunomodulatory effects of EVs as detected at the molecular level.